Shunichiro Kuramitsu
- Oncology top 10%
- CAR-T cell therapy research 8
- Neurology top 5%
- Genetics top 10%
- Glioma Diagnosis and Treatment 6
- Virus-based gene therapy research 2
-
- T-cell and B-cell Immunology 4
- Immunotherapy and Immune Responses 3
- Immune Cell Function and Interaction 2
-
- Meningioma and schwannoma management 3
-
- Brain Metastases and Treatment 4
- Co-authors
- Carl H. JuneAvery D. PoseyKeisuke WatanabeYoshihisa KidaTakashi YamamotoHiroshi IizukaTakenori KatoToshinori Hasegawa
- Partner nations
- JapanUnited States
In The Last Decade
Shunichiro Kuramitsu
16 papers receiving 775 citations
Hit Papers
Peers
Comparison fields: 5 of 61
- Oncology 441
- Neurology 197
- Genetics 93
- Immunology 183
- Epidemiology 228
Countries citing papers authored by Shunichiro Kuramitsu
This map shows the geographic impact of Shunichiro Kuramitsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunichiro Kuramitsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunichiro Kuramitsu more than expected).
Fields of papers citing papers by Shunichiro Kuramitsu
This network shows the impact of papers produced by Shunichiro Kuramitsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunichiro Kuramitsu. The network helps show where Shunichiro Kuramitsu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Shunichiro Kuramitsu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 1 | |
| 6 | 2023 | 27 | |
| 7 | Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cellsbreakdown → | 2023 | 104 |
| 8 | 2022 | 2 | |
| 9 | 2022 | 46 | |
| 10 | 2022 | 1 | |
| 11 | 2022 | 0 | |
| 12 | 2018 | 168 | |
| 13 | 2017 | 43 | |
| 14 | 2016 | 80 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 53 | |
| 17 | 2014 | 16 | |
| 18 | 2014 | 47 | |
| 19 | 2012 | 186 |
About Shunichiro Kuramitsu
Shunichiro Kuramitsu is a scholar working on Genetics, Oncology and Immunology, having authored 19 papers that have together received 784 indexed citations. Recurring topics across this work include CAR-T cell therapy research (8 papers), Glioma Diagnosis and Treatment (6 papers), Brain Metastases and Treatment (4 papers), T-cell and B-cell Immunology (4 papers), Meningioma and schwannoma management (3 papers), Immunotherapy and Immune Responses (3 papers), Virus-based gene therapy research (2 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Oncology (441 citations), Neurology (197 citations) and Genetics (93 citations). Shunichiro Kuramitsu has collaborated with scholars based in Japan and United States. Frequent co-authors include Carl H. June, Avery D. Posey, Keisuke Watanabe, Yoshihisa Kida, Takashi Yamamoto, Hiroshi Iizuka, Takenori Kato, Toshinori Hasegawa, Atsushi Natsume and Kazuya Motomura. Their work appears in journals such as Immunity, Cancer Research and Journal of neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.